Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs

Key Takeaways Elevance Health's Q2 EPS of $8.84 missed estimates and declined 12.6% year over year. Higher premiums and product revenues drove a 14.3% rise in operating revenues to $49.4 billion. Rising costs in ACA and Medicaid pressured margins, with the adjusted EPS guidance cut to $30 for 2025.Elevance Health, Inc. (ELV) has reported second-quarter 2025 adjusted earnings per share (EPS) of $8.84, which missed the Zacks Consensus Estimate by 3.5%. The bottom line decreased 12.6% year over year.Operatin ...